We're relaunching PerfAgents with a renewed focus on performance test orchestration-bringing load testing, real user ...
The unified JavaScript runtime standard is an idea whose time has come. Here’s an inside look at the movement for server-side JavaScript interoperability.
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune ...
The Plant Base is the go to B2B news platform for the plant-based food and beverage industry. Refreshment is your ultimate resource for staying informed and up-to-date on the water cooler, vending, ...
Ethiopia’s Farmer-Led Irrigation Development (FLID) program marks a shift from top-down irrigation to farmer ownership. Backed by the World Bank through the Food Systems Resilience Program, FLID ...
For this week’s Ask An SEO, a reader asked: “Is there any difference between how AI systems handle JavaScript-rendered or interactively hidden content compared to traditional Google indexing? What ...
LAS VEGAS, Jan 6 (Reuters) - Amazon's (AMZN.O), opens new tab cloud unit has partnered with German automotive hardware supplier Aumovio (AMV0n.DE), opens new tab to support the commercial rollout of ...
AI-powered platform to predict patient safety and efficacy profiles, unlocking precision-driven oncology development BostonGene, the developer of the leading AI foundation model for tumor and immune ...
AI is a strategic enabler throughout the entire development and test process. dSPACE has been exploring how the latest developments in generative and agentic AI technologies can support ...
Northrop Grumman test-fired a solid rocket motor called SMASH!22 Dec. 4 as part of its SMART Demo development program. Credit: Northrop Grumman WASHINGTON — Northrop Grumman tested a solid rocket ...
Amazon Web Services Inc. today introduced a new feature for Kiro, the company’s artificial intelligence-powered agentic coding environment for software developers, adding new “powers” that bring ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results